Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma
Naglaa F. Alsalawy; Rania K. Darwish; Manal M. Kamal; Ahmed E. ElTaweel; Hend I. Shousha; Tamer M. Elbaz
Author Information: Department of Clinical and Chemical Pathology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.